<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb1270">
 <label>254</label>
 <element-citation publication-type="journal" id="rf9083">
  <person-group person-group-type="author">
   <name>
    <surname>Kajani</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Apramian</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vega</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ubhayakar</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Neuroleptic malignant syndrome in a COVID-19 patient</article-title>
  <source>Brain Behav Immun.</source>
  <volume>88</volume>
  <year>2020</year>
  <fpage>28</fpage>
  <lpage>29</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bbi.2020.05.042</pub-id>
  <pub-id pub-id-type="pmid">32425332</pub-id>
 </element-citation>
</ref>
